Price$860.44+96.80 (+12.68%)
2026-05-192026-08-21
News · 26 weeks77-46%
2026-03-012026-08-23
Mix4990d
- Insider35(71%)
- SEC Filings8(16%)
- Earnings2(4%)
- Other2(4%)
- Offering1(2%)
- Dividends1(2%)
Latest news
25 items- ANALYSTRBC Capital Mkts initiated coverage on McKesson with a new price targetRBC Capital Mkts initiated coverage of McKesson with a rating of Sector Perform and set a new price target of $845.00
- INSIDERSEC Form 4 filed by EVP and Chief Strategy Officer Srinivasan Ramesh (Nmn)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERDirector Lerman Bradley E sold $268,590 worth of shares (301 units at $892.33), closing all direct ownership in the company (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERNew insider Srinivasan Ramesh (Nmn) claimed ownership of 11,959 shares (SEC Form 3)3 - MCKESSON CORP (0000927653) (Issuer)
- SECSEC Form 10-Q filed by McKesson Corporation10-Q - MCKESSON CORP (0000927653) (Filer)
- PRMcKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS GuidanceMcKesson Corporation (NYSE:MCK) has released its fiscal 2027 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 5 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company’s earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inv
- SECMcKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MCKESSON CORP (0000927653) (Filer)
- SECMcKesson Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - MCKESSON CORP (0000927653) (Filer)
- INSIDERSEC Form 4 filed by Director Hinton James H.4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERSEC Form 4 filed by Director Doughtie Lynne M4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERDirector Wilson-Thompson Kathleen was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERSEC Form 4 filed by Director Dunbar Webster Roy4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERDirector Caruso Dominic J was granted 277 shares, increasing direct ownership by 43% to 927 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERSEC Form 4 filed by Director Gerberding Julie L.4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERSEC Form 4 filed by Director Lerman Bradley E4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERDirector Martinez Maria was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERSEC Form 4 filed by Director Ozan Kevin M4 - MCKESSON CORP (0000927653) (Issuer)
- INSIDERSEC Form 4 filed by Director Dunsire Deborah4 - MCKESSON CORP (0000927653) (Issuer)
- PRMcKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per ShareThe Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.94 per share of common stock, a 15% increase from $0.82 per share in the prior quarter. The dividend will be payable on October 1, 2026, to shareholders of record on September 1, 2026. "Today’s announcement marks our tenth consecutive year of dividend growth, reflecting the strength of our business, our disciplined approach to capital allocation and our commitment to returning capital to shareholders," said Brian Tyler, chair and chief executive officer. "We remain focused on leveraging our financial strength to execute against the company priorities and create sustainable, long-term valu
- INSIDERChief Executive Officer Tyler Brian S. sold $6,715,898 worth of shares (8,463 units at $793.56) as part of a pre-agreed trading plan, decreasing direct ownership by 59% to 5,919 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- SECMcKesson Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MCKESSON CORP (0000927653) (Filer)
- SECSEC Form DEFA14A filed by McKesson CorporationDEFA14A - MCKESSON CORP (0000927653) (Filer)
- PRMcKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release DateMcKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson’s Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he
- INSIDERChief Executive Officer Tyler Brian S. sold $6,559,925 worth of shares (8,463 units at $775.13) as part of a pre-agreed trading plan, decreasing direct ownership by 37% to 14,382 units (SEC Form 4)4 - MCKESSON CORP (0000927653) (Issuer)
- SECSEC Form DEFA14A filed by McKesson CorporationDEFA14A - MCKESSON CORP (0000927653) (Filer)
MCK FAQ
7 questionsWhat does McKesson Corporation do?
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and...Where does MCK stock trade?
McKesson Corporation (MCK) is listed on NYSE.What sector and industry is MCK in?
McKesson Corporation operates in the Health Care sector, Other Pharmaceuticals industry.Does MCK pay a dividend?
Yes. MCK's next ex-dividend date is 2026-09-01 with a declared cash dividend of $0.94 per share, payable 2026-10-01.What are analysts saying about MCK?
McKesson Corporation has had 8 recent analyst actions on file. The most recent action was from RBC Capital Mkts: Sector Perform on 2026-08-19.What companies are similar to MCK?
Notable peers in the same industry include CAH (Cardinal Health Inc.), BDX (Becton Dickinson and Company), HSIC (Henry Schein Inc.). Compare MCK side-by-side with any of them on Quantisnow.How can I track MCK on Quantisnow?
Quantisnow aggregates McKesson Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MCK to receive live email and push alerts on every new disclosure.